Attendee search 

Because of restricted inherent capacity of regeneration and healing, the restoration of function to damaged heart remains formidable contest. In our laboratory we are trying to develop protocols for regenerating pig heart tissues by first stripping of cells and then repopulating the acellular scaffold with human stem cells. Such tissue engineered hearts may be potentially used for transplantation in future.

APL is a full scale Contract Development and Manufacturing Organisation. Modern manufacturing processes and staff with cutting edge competence make APL a competent partner and supplier. We develop and manufacture pharmaceuticals and consumables for companies throughout the world. Our offers extend from the early research phase to commercial product.

Recopharma is a biotechnology company, founded in 2004. The company is based in Gothenburg, Sweden, at the Biotech Center.

Recopharma carries out activities in the field of ophthalmology, developing potential products for treatment of eye diseases. The Company has developed a unique technology, with many potential applications,  that uses mucins, which naturally occur in lacrimal fluid, where they protect, lubricate and help keep the tear film intact.

Based on extensive experience in Drug development, encompassing Global project leadership, modeling and simulation and portfolio management Captario was founded to create a new generation of Pharma IT.

The Colab software helps cross-functional teams define and drive a drug development strategy from CD selection to launch. Using Colab, the teams manage project uncertainties and are supported by advanced visualization, modeling and simulation in making critical decisions.

Business Region Göteborg AB is dedicated to strengthening and developing trade and industry in the Göteborg region in West Sweden. Our goal is to contribute to sustainable economic growth, a high level of employment and a diversified economy. The department of Business Establishment and Investment at Business Region Gothenburg is a “one-stop-shop, which aims at simplifying and assisting all companies planning to invest, relocate to or expand its operations in West Sweden.

Business Region Gothenburg is the first port of call for foreign companies or organisations looking for licensing opportunities, R&D collaboration, technology access, feasibility studies, potential partners and investment opportunities in West Sweden. Furthermore, We identify business opportunities abroad for our key accounts in West Sweden’s Life Science cluster which include but are not limited to research Institutes, Life Science companies, Science parks and incubators.

By getting in contact with us you will receive all information from a single player. We will also establish the necessary contacts and help you from introduction to business case. All our services are free-of-charge. We also help in booking meetings, site visits and finding premises if needed for entering the Scandinavian market.

Redoxis is a Swedish company which main competence is target validation and preclinical development of novel therapies for autoimmune diseases. Redoxis focus both on own target discovery research and professional CRO services on preclinical drug and target evaluation in animal models. Our main interest and knowledge is within rheumatoid arthritis (RA) and multiple sclerosis (MS) and we have several years of expertise of animal models for these diseases. We offer services regarding evaluation of novel drugs and therapeutic targets both in vitro, ex vivo and in vivo in animal models and we can assist in design, performance and interpretation of the results from the experiments. Our model systems are well validated and as a small company can offer flexible study design through communication with our sponsors. 

Redoxis drug development project is characterized by protected small molecules targeting target of immunological relevance that are regulated by Redoxis stimulation and of importance in CD4 T cell receptor signaling immune responses. Of primary focus are autoimmune disorders like the orphan disease Guillain-Barrés Syndrome (GBS), Multiple Sclerosis (MS) and Rheumatoid Arthritis (RA).

Mevia develops intelligent pharmaceutical solutions to support patient adherence and increase the quality of drug treatments. With our innovative technology, each medical event is automatically registered and if a dose is forgotten the patient can immediately recieve a reminder. Our service enables closer contact between patients, healthcare and relatives. 

We are a Nordic law firm with a simple business concept : to create value for you. This is the guiding principle in everything we do. This means that we always look for solutions which not only comply with the law, but which also generate commercial advantages. It also means that it's not enough for us to obtain results. We want good results. Irrespective of the industry. Irrespective of which Nordic country is involved. Cross-border.

The business operations conducted within life science companies often involve major risks and opportunities for significant earnings. The risks come not only from the advanced scientific and supervisory environment but also from complicated business models. A key to success is for companies to be able to handle these risks. This demands that the contracts which are produced exhaustively govern all of the risks and that these risks are appropriately allocated between the parties.

NORDIA has a practice group with lawyers experienced in life science to assist national and international companies in the area, both listed companies and private companies.